Navigation Links
Hypertension researcher encourages colleagues to expand their focus
Date:9/14/2013

Augusta, Ga. Dr. David Pollock has a simple message for fellow hypertension researchers: think endothelin.

In a country where better than 30 percent of adults have high blood pressure and 50-75 percent of those have salt-sensitive hypertension, he believes the powerful endothelin system, which helps the body eliminate salt, should not be essentially ignored.

However, the research and clinical world focus on suppressing a better-known system, which prompts the body to hold onto salt, said Pollock, Chief of the Section of Experimental Medicine at the Medical College of Georgia at Georgia Regents University.

Pollock is giving the 2013 Lewis K. Dahl Memorial Lecture Sept. 14 during the American Heart Association's High Blood Pressure Research 2013 Scientific Sessions in New Orleans.

"If you look at blood pressure regulation and salt-controlled sodium excretion, everybody sees the renin-angiotensin-aldosterone system. That is what the books say." Pollock said. No doubt the system is important. When blood volume is low, the kidneys secret renin to make the hormone angiotensin. Angiotensin drives blood pressure up by promoting sodium retention directly and by stimulating release of aldosterone, a hormone that prompts the kidneys to resorb sodium rather than eliminate it in the urine.

It's a protective system intended to ensure that the body has enough sodium to keep blood pressure at sufficient levels to sustain life. It's also a system that's somehow dysregulated in some hypertensive patients who take ACE inhibitors or angiotensin receptor blockers to turn it down.

Since most Americans already turn down this system by eating too much salt, Pollock argues that enhancing sodium excretion might be a better approach, particularly for those not responding to existing therapies.

In fact, when an animal on a high-salt diet is given a drug to block endothelin's B receptor, blood pressure goes up 50 points, Pollock said. He regularly reminds research colleagues that blocking angiotensin receptors won't produce nearly such dramatic results. In fact, he thinks problems with the endothelin system possibly resulting from a developmental defect or high-salt exposure early in life may help explain why some folks who eat a high-sodium diet get high blood pressure and others don't. But this leads to one of the weak points of endothelin and probably part of the reason it's not been top of mind for hypertension researchers, he said.

When the salt-eliminating B receptor is inactive for whatever reason, endothelin's A receptor, which actually constricts blood vessels, gets activated so blood pressure goes up, Pollock said. An interesting aside is that, at least in the short term, higher blood pressure makes it easier for the kidneys to eliminate sodium without the help of the B receptor.

Endothelin was labeled the most potent vasoconstrictor ever described when it was first purified in the late 1980s, but it was a long time before there was any attention paid to the diametrically opposed actions of the B receptors, Pollock said. Receptor antagonists didn't exist in those early days anyway and efforts to block endothelin synthesis didn't work well because there were so many forms of the enzyme that make endothelin scattered throughout the body, he said.

While still working for a pharmaceutical company, Pollock helped develop on one of the first A receptor antagonists that's now in the final stage of clinical trials for chronic kidney disease. Since the early patents on the endothelin-blocking drugs are about to run out, it's unlikely that new drug development dollars will be in the offing, Pollock said. The good news is that drugs already in use for pulmonary hypertension, which shut down the A receptors, likely have crossover potential for salt-sensitive hypertension, Pollock said.

Pollock's studies have shown that the kidney's endothelin B receptor plays a critical role in eliminating both acute and chronic salt loads by activating nitric oxide, a potent dilator of blood vessels, in the kidneys. In fact, the kidneys make more endothelin than any place in the body.

"We had no idea it was going to be this important in salt regulation," Pollock said. "The main point I want to make is that people studying hypertension, salt-sensitivity particularly, need to consider what is happening to the endothelin system when they are doing their research. There are only a handful of us who have been studying it with any real intensity."

Key questions include how the B receptor gets turned off. Interestingly, researchers already know that the angiotensin system shuts the receptor down when patients are on a low-salt diet. Do hypertensive patients on a low-salt diet also have their B receptors turned off? "It's a good question and another reason that targeting the renin-angiotensin-aldosterone system may not give you the whole answer," Pollock said.

The Lewis K. Dahl Memorial Lecture was established in 1988 by the Council for High Blood Pressure Research in honor of Dahl's pioneering work on the relations between salt, the kidney and hypertension, and for establishing the Dahl salt-sensitive rat, a major genetically based experimental model of hypertension. Pollock has been a fellow of the council since 2000.


'/>"/>

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University
Source:Eurekalert

Related biology news :

1. Second-generation drug used for hypertension aids heart function independent of blood pressure
2. OHSU study shows that a molecule critical to nerve cells increases drammatically during hypertension
3. Sodium transporter appears likely target for treating salt-sensitive hypertension
4. Study uncovers mechanism for how grapes reduce heart failure associated with hypertension
5. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
6. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
7. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
8. U of Alberta researcher steps closer to understand autoimmune diseases
9. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
10. UNH researchers find African farmers need better climate change data to improve farming practices
11. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
(Date:2/22/2017)... , Feb. 22, 2017 Scientists propose ... inflammation and organ damage in Gaucher and maybe other ... risks and lower costs than current therapies. ... Hospital Medical Center , which also included investigators from ... , report their data Feb. 22. The study was ...
(Date:2/22/2017)... Dublin - Research and Markets ... (Bio-Pesticide) Market-By Type, By Application, By End User, By Region, By ... ... Protection Market is forecasted to grow at a CAGR of 11.33% ... biological crop protection market is driven by the surging demand for ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  Creative ... expansion of its translational research program using its ... of laboratory facilities in San Diego.  The Company ... BioLabs facility, a biotechnology incubator sponsored by the ... In November 2016, the Company obtained an ...
Breaking Biology Technology: